This paper describes the application of capillary column gas liquid chromatography (GLC) to the analysis of urine samples for drugs of abuse.
This paper describes the application of capillary column gas liquid chromatography (GLC) to the analysis of urine samples for drugs of abuse.
A simple basic extraction into butylacetate is followed by temperature programmed analysis from 90°C to 310°C to provide a comprehensive screen for basic drugs. Retention data are presented for approximately 300 compounds.
The use of capillary column GLC is compared with packed column methods used previously in this laboratory. The reproducibility of retention data and sensitivity of this analysis for several commonly encountered drugs are presented.
Capillary gas-liquid chromatography (GLC) with nitrogen-phosphorus detection (NPD) has proved a useful tool for identifying basic drugs in many laboratories':" and has performed a dual role in this laboratory since 1984. Firstly it is used to confirm the identity of amphetamine type drugs detected using the Syva EMIT technique. Confirmation is needed as the antibody in these kits cross-reacts with many related drugs such as: methyl amphetamine, ephedrine, phenylpropanolamine and methylenedioxymethylamphetamine (MDMA).
Secondly it is used as a backup to the existing in-house TLC method (adapted from Berry and Grove"), Although thin-layer chromatography (TLC) provides a cheap and rapid method for identifying the commonly used opioid drugs, urine extracts may also contain drugs prescribed to relieve anxiety, depression, withdrawal symptoms or other medical conditions. These extracts yield a multitude of spots on TLC which may preclude confident interpretation of the chromatograms. TLC is also adversely affected by 'oily' extracts containing excipients such as polyethylene glycol (present in some temazepam preparations), and overloading as a result of heavy abuse of, for example, dihydrocodeine. To aid the identification of these compounds by GLC approximately 250 substances were characterised.
By using a temperature programme the same column, equipment and GLC conditions can be applied to the analysis of samples in both the above categories.
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The combination of splitless Injection with capillary column GLC has been shown to provide a simple and sensitive method for rapid drug screening.V? It is ideally suited to the automatic processing of large numbers of samples as it allows the use of standard syringes with steel needles which are easily wielded by automatic injectors. Furthermore, by injecting onto a quartz glass injection liner, non-volatile contaminants can be deposited there rather than allowed to accumulate on the analytical column.
Materials and methods

INSTRUMENT ATION
All analyses were performed on a model 5890 gas chromatograph (Hewlett-Packard, Winnersh, UK) equipped with a model 7673A automatic liquid sampler, a nitrogen-phosphorus detector and a capillary column split-splitiess inlet system. A 25 m HP-5, wide bore (0,32 mm i.d.), thick film (0,52 jlm) cross-linked fused silica column was used (Hewlett-Packard No. 19091-112) . A model 3392A recording integrator (Hewlett-Packard) was used to monitor the GC output and store GLC and autoinjector parameters.
GC OPERATING PARAMETERS
Helium was used as the carrier gas. The column head pressure was 19psi, which gave a flow rate of approximately 3·5 mL(min. The septum purge was I mL(min and the purge flow 40 mL(min. Other flow rates were: nitrogen (make-up gas) 26 mL(min, air 100 mL(min and hydrogen 4 mL( min.
The injector was heated to 250°C and the detector to 300°C. The bead current was adjusted to give a signal of 25 at rest. This usually corresponded to a bead current of 600-700, beads that required a higher current had a shorter life expectancy. The range was set at 2, attenuation at 4, chart speed at I ern/min, peak width at 0,04, and threshold to S. During the analysis the column temperature was programmed from an initial 90°C for O'5 min then raised at 40"C per minute to 250°C for 0·1 min and then raised again at SoC per minute to 310°C.
The injector was used in the splitless mode so that the entire injection was allowed to pass onto the column before the inlet purge was activated at 0·4 minutes.
CHEMICALS AND REAGENTS
HPLC grade butylacetate was used for all extractions (Rathburn Chemicals Ltd, Walkerburn, Peebleshire, UK). Analar grade methanol (BDH Chemicals Ltd, Poole, UK) was used to prepare I giL stock solutions of all standards and internal standards. Sodium hydroxide (BDH Chemicals) was prepared as a 1·0 M solution in distilled water. Pure samples of drugs and some metabolites were provided by the manufacturers.
INTERNAL STANDARD
Prazepam (5 mg/L) in butylacetate was used as the internal standard.
STANDARDS
Methanolic solutions (I g/L) were diluted with butylacetate or 2-methylpropan-I-ol (BDH Chemicals) to provide 10 mg/L working solutions which were chromatographed to provide a library of retention data relative to prazepam. STANDARD 
MIXTURES
Amphetamine and related compounds are unstable in butyl acetate. Standard mixtures containing these drugs were therefore prepared by diluting the I g/L stock solutions in 2-methylpropan-1-01, a solvent with similar volatility to butylacetate. A mixture of basic drugs was prepared by dilution of the I giL stocks with 2-methylpropan-1-01( Fig. I) . All drugs were present at a concentration of 10 mg/L and 2 J,lL of solution was injected for calibration.
EXTRACTION PROCEDURES
One millilitre of urine, 250 J,lL of 1·0 M sodium hydroxide and 500 J,lL of prazepam internal standard solution were added to a clean 4·5 mL polypropylene tube (Sarstedt, FRG) vortex mixed for 30 s and centrifuged at 3000 rpm for approximately 10 min. Three hundred microlitres of the butylacetate layer was transferred to 1 mL autosampler vials using an Eppendorf 100-1000 J,l1 adjustable pipette and capped with aluminium crimp tops containing rubber septa (Chromacol Ltd, Glen Ross House, London, UK). Two microlitres were injected onto the GC. Peaks were identified by calculating retention time relative to the internal standard, prazepam, and comparing these to the listed values (Table I) . Vials containing pure butyl acetate were placed between urine extracts and chromato graphed to minimise the risk of wash-over following highly concentrated extracts.
VOLUNTEER STUDY
After obtaining permission from the Ethical Committee of Guys Hospital Medical School, healthy volunteers were prescribed a single therapeutic dose of various drugs of abuse. Urine samples were collected at intervals for the following 48 h and analysed using the GLC method described. The details are presented in Table 3 .
Results and discussion
Butylacetate has proved to be a suitable solvent with high extraction efficiencies for methadone, amphetamine and codeine. However, amphetamine and related compounds degrade if left in butyl acetate for long periods (approximately 20% of the amphetamine extracted from a I mg/L standard was lost in four days at room temperature). Consequently, long term standard mixtures must be prepared in an alternative solvent (2methylpropan-l-ol) and sample extracts must be analysed within a week to avoid significant drug loss.
The oven temperature starts at 90°C, significantly below the boiling point of butyl acetate which is 109°C. This allows vaporisation of the extract in the injector, which is at 250°C, and subsequent condensation on the analytical column (cold trapping). A fast 40°Cjmin ramp to 250°C is then followed by a slower SOC/min ramp to 310°C during which the majority of compounds elute. The run time is 17·00 min with approximately 4 min required for the machine to cool down before the next injection. Therefore each injection takes approximately 21 min.
Retention data for a large number of drugs and metabolites are listed in Table 1 and in alphabetical order in the Appendix. Compounds labelled as associated peaks in Table 1 (e.g. diethylpropion assoc.) are suspected metabolites whose Procyclidine  7·062  0·642  118  Dextropropoxyphene  7·073  0·643  119  Butriptyline  7·161  0·651  120  Amitriptyline  7·172  0·652  121  Cocaine  7·183  0·653  122 Atropine 7·227 0·657 
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hemical structure is uncertain and therefore cannot be definitely assigned as metabolites. When this machine was installed in 1984 it replaced two packed column systems. New retention data were generated relative to prazepam as described above. The use of Kovat's Retention Indices" for peak identification was considered at the outset of this work. They allow cross-reference to tables ofretention data generated by other laboratories. However, this would have entailed splitting the column effluent to allow for hydrocarbon detection by a flame-ionisation detector. This can result in loss of sensitivity, broadening of peak shape and an increase in the amount of time spent maintaining the equipment. Moreover it was felt that the extra time and effort required to institute and operate such a system was not justified for the large number of relatively uncomplicated analyses that was required.
A standard mixture of commonly encountered drugs was chromato graphed prior to any samples (Fig. I) . This standard contained two polar drugs, trimethoprim and quinine. It was found that if the injection liner or column were contaminated, these peaks began to tailor even disappear completely. The chromatography could be restored by immersing the injection liner in chromic Fresh blank urine gave rise to no peaks--other than the almost universal caffeine, and (especially amongst drug abusers) nicotine-at the GC and integrator settings detailed above.
Although it would have been desirable to be able to confirm the presence of morphine using this GC method, in our hands it was found that morphine could only be eluted, even from standard solutions, on new columns. After a few injections of patient extracts morphine failed to elute. No such problems were encountered with related drugs such as codeine, dihydrocodeine and pholcodine. Codeine and dihydrocodeine were not resolved on this system, however the inhouse TLC system used in this laboratory differentiates between these drugs.
REPRODUCIBILITY OF RETENTION DATA
Example traces of the standard mixture (see above), run at the start ofa batch of samples, were retained over a four month period. These were then used to calculate the coefficient of variation for the relative retention times (RRT) of each drug in this mixture.
The earlier eluting drugs (amphetamine to nicotine) were more prone to variability in retention time. These drugs elute during the 40°C/min ramp which appears to exceed the ability of the equipment to control the oven temperature precisely. However, the precision was sufficient to differentiate most of the compounds that eluted in this region of the chromatogram. One exception to this was found in one of the NEQAS quality control samples circulated in 1988. This contained N-ethylbenzenamine a contaminant leached into the urine sample from the rubber stopper. This does not separate from amphetamine. If samples are received in rubber stoppered bottles, amphetamine positives should be confirmed by using the 'Acetone Shift' method described by Beckett." The variation in relative retention times of other drugs was very low, the exceptions being relatively polar drugs which tended to give tailing peaks. As in packed column GLC, this gave rise to a variation in retention time with the amount injected. Drugs in this category include quinine and trimethoprim as already mentioned and, to a lesser extent, caffeine. In practice a margin of ±0·005 RRT units served as a window when comparing calculated RRT with library data.
The present column has been used for at least 10000 injections (just over a year) and the only maintenance required has been periodic cleaning of the injection liner and occasional removal of the first 15 em of the analytical column. A good NPD bead/collector was found to survive six months of regular use. We did, on occasions, receive faulty collectors, but these were willingly replaced by the manufacturers.
This system requires far less maintenance than the packed column methods previously used for detecting amphetamines and other basic drugs in this laboratory. The columns used (Apiezon L KOH and Carbowax 20M KOH for the amphetamines and OY-l and Poly A-103 for other basic drugs) needed periodic re-packing due to bleeding of the stationary phase and accumulation of nonvolatile residues plugging the top of the column.
Since compiling our library of retention data in 1984, six capillary columns have been used. We have found no need to alter the recorded reten- The resolving power of the capillary column and the reproducibility of RRT's (see Table 2 ) allows many compounds to be identified immediately. However some compounds elute coincidentally or very close together. Referral back to the TLC plates will often rule out one or more possibilities, but often the detection of metabolites on the GLC system enables the correct identification to be made. For example, although fenfiuramine and pargyline give the same RRT, fenfiuramine will normally be accompanied by its major urinary metabolite norfenfiuramine. The tricyclic antidepressants, although structurally similar, give characteristic metabolite patterns, so that even if two parent compounds are not resolved their desmethyl and hydroxy metabolites often are. Some peaks that were previously assumed to be the parent compound in urine samples analysed on packed columns, have been resolved into parent drug and several metabolites by using capillary columns. For example, chlorpheniramine and brompheniramine both give a single peak on packed columns, but are resolved into parent compound and two metabolite peaks on a capillary column. This emphasises the need to compile data bases with RRT's not only for the parent drugs, but also for any metabolites which may be extracted from urine samples.
The presence of one drug can be masked by coelution of another or its metabolites. This is particularly likely when chlormethiazole is prescribed. This drug generates an abundance of urinary metabolites, and their pattern varies from one individual to another. It is also possible that these metabolites may be mistaken for other drugs. These chromatograms must therefore be examined with great care and any inferences corroborated by an alternative technique.
SENSITIVITY OF DETECTION
The quantitative limits of detection for the drugs listed in Table 3 were determined by extracting and chromato graphing blank urine samples spiked at concentrations of 0,1, O' 25, O' 5, 1,0, and 2·0 mg/L, All were detectable at a concentration of 0·25 rng/L, allowing detection of all save dextromoramide following single therapeutic doses (see below). Dextropropoxyphene is extensively metabolised and normally only nordextropropoxyphene and other degradation products are detectable in urine. Since a quantitative solution of this metabolite was not available for study, no limit of detection could be assigned. Users of drug abuse screening services often enquire as to how long after a dose the drug remains detectable in urine. Accordingly, drug free volunteers were given single therapeutic doses of drugs and asked to collect urine samples at 4, 8, 12, 24, 36 and 48 h post ingestion. All drugs save cocaine were taken orally; cocaine was administered by nasal insufflation (snorting). Results are presented in Table 3 . With the exception of dextromoramide the parent drugs or metabolites were detectable for a minimum of 12 h following a single dose.
Dextromoramide was not detected in any sample from the three volunteers given this drug. This supports the findings of other workers, that very little unchanged drug is excreted in the urine. (A Clatworthy, personal communication). Dextromoramide and an associated peak have been found in several urines from drug abusers, presumably following larger doses of this drug.
Conclusion
Wide bore capillary column GLC has proved to GLC of drugs of abuse 439 be an effective and valuable addition to a drug abuse screening service. The equipment requires very little maintenance and the chromatography has proved far more reproducible than that previously achieved by using packed columns. This method has proved a valuable tool, helping the correct identification of amphetamine type drugs detected by immunoassay and unidentified compounds detected by our in-house TLC system. Many of the compounds commonly present in urine from drug abusers can be identified when retention data from this GLC method are used in conjunction with TLC Rf data. 
